Centrum Medyczne Pulawska Sp. z o.o.

Piaseczno 7 trials 1 recruiting

7 Registered trials

1 Currently recruiting

Organisation

Centrum Medyczne Pulawska Sp. z o.o.

Location

Piaseczno, Poland

Identifier

ORG-100044311

Address

Ul. Pulawska 49, 05-500, Poland

Departments

2203; Centrum Medyczne Pulawska Sp. z o.o.
2203: Centrum Medyczne Puławska Sp. z o.o.
2203:Ophthalmology
Cardiology
Medical Center
not applicable
Ophthalmology

Clinical trials at this site (7)

Search interface

An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants with Active Thyroid Eye Disease (TED) Recruiting

2024-514972-42-00 Thyroid eye disease 5 2025-02-25
A Safety, and Tolerability Study of VRDN-003 in Participants with Thyroid Eye Disease (TED) Ended

2024-519417-57-00 Thyroid eye disease 5 2025-06-25
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants with Moderate-to-Severe Thy… Ended

2023-503669-50-00 Moderate-to-Severe Thyroid Eye Disease 5 2023-12-27
A study to evaluate the efficacy and safety of gliclazide MR in patients with type 2 diabetes inadequately controlled with dapagliflozin wit… Ended

2024-511408-18-00 Type 2 Diabetes inadequately controlled with dapagliflo 5 2024-07-15
An open-label study for participants who are non-responders at the end of treatment assessment on the VRDN-001-101 and VRDN-001-301 pivotal … Ended

2023-507350-33-00 Thyroid eye disease 5 2024-06-25
A Safety, Tolerability and Efficacy Study of VRDN-001 in Persons with Chronic Thyroid Eye Disease (TED) Ended

2023-507217-10-00 Thyroid eye disease 5 2024-04-12
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke Ended

2023-503673-38-00 Adults at high risk of cardiovascular events without pr 5 2019-05-24